# SkinBioTherapeutics Plc Technology, SkinBiotix®, Shows Positive Results

- Link: https://www.directorstalkinterviews.com/skinbiotherapeutics-plc-technology-skinbiotix-shows-positive-results/412749395
- Published: 2018-04-17T07:11:06+01:00
- Author: Giles Arbor

**SkinBioTherapeutics plc** (LON:SBTX), a life science company focused on skin health,
announced today that the ‘cream’ formulation of its SkinBiotix® technology has passed
effectiveness studies in models of skin. The cream formulation will now undergo 
further testing for stability in the coming weeks.

SkinBioTherapeutics’ platform, SkinBiotix®, utilises extracts of probiotic bacteria
for application to the skin. The Company has shown in skin models that its technology
can improve the skin’s barrier function (e.g. keep moisture in and protect skin 
from infection).

The cream has been formulated to contain SkinBioTherapeutics’ proprietary technology,
SkinBiotix®. A crucial feature of the formulation phase is to test that the cream-
SkinBiotix® combination retains the same beneficial properties as the original technology.

One important effect of SkinBiotix® in proof of concept studies was the increase
of a specific skin protein essential to the barrier function of the skin. This effect
was also shown when tested as a cream formulation. The data further showed a direct
correlation between the amount of SkinBiotix® within the cream and the level of 
the protein present. Work on creating skin lotion and gel formulations is ongoing.

>  **Dr Catherine O’Neill, CEO of SkinBioTherapeutics Plc, commented:** “The incorporation
> of our SkInBiotix® technology into an effective cream formulation is a major milestone
> in the development of products for the cosmetic market and, subject to stability
> testing, allows us to create formulations for our [human study](https://www.directorstalkinterviews.com/company/open-orphan-plc/orph.l)
> later this year.”

Share on: